Amedisys, Inc. (NASDAQ:AMED) Receives $100.75 Average Target Price from Analysts

Amedisys, Inc. (NASDAQ:AMED) has been assigned an average recommendation of “Hold” from the six brokerages that are currently covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $100.75.

Separately, Stephens reissued an “equal weight” rating and set a $101.00 target price on shares of Amedisys in a research note on Wednesday, February 12th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Blue Trust Inc. raised its holdings in shares of Amedisys by 55.1% in the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock worth $34,000 after acquiring an additional 124 shares during the last quarter. HBW Advisory Services LLC bought a new position in shares of Amedisys in the fourth quarter valued at approximately $38,000. Versant Capital Management Inc grew its holdings in Amedisys by 68.5% during the fourth quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock worth $41,000 after buying an additional 183 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in Amedisys in the 4th quarter valued at $55,000. Finally, KBC Group NV purchased a new position in Amedisys during the 3rd quarter worth $63,000. Institutional investors own 94.36% of the company’s stock.

Amedisys Stock Down 0.1 %

Amedisys stock opened at $92.55 on Wednesday. The firm has a market cap of $3.03 billion, a price-to-earnings ratio of 36.73, a PEG ratio of 1.82 and a beta of 0.73. Amedisys has a 52-week low of $82.15 and a 52-week high of $98.95. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The firm has a 50 day moving average price of $90.39 and a two-hundred day moving average price of $93.50.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.